17/12/2007 (Agence Europe) - In a press release, the French UMP MEP Françoise Grossetête has welcomed the creation of the joint company for the Innovative Medicines Initiative (IMI). This partnership between laboratories under the umbrella of the EFPIA and the European Commission constitutes “major progress and is highly promising for large-scale research programmes, moving away from the traditional approach of public funding for European projects”, Françoise Grossetête observes. The...